Treat U Overview
- Status
-
Acquired/Merged
- Employees
-
5
- Latest Deal Type
-
M&A
Treat U General Information
Description
Developer of a targeted nanotechnology-based platform designed to deliver drugs with technological advantages in the oncology area. The company's platform is an appealing technology for the pharmaceutical industry that brings value to patients, physicians, and the healthcare system, thereby enabling them to develop effective and safe therapeutics for the treatment of breast cancer.
Contact Information
Website
www.treatu.pt(Operating Subsidiary)
Corporate Office
- Parque Industrial de Taveiro
- Lote 44
- Coimbra, 3045-508
- Portugal
Corporate Office
- Parque Industrial de Taveiro
- Lote 44
- Coimbra, 3045-508
- Portugal
Treat U Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 31-Mar-2020 | Completed | Generating Revenue | |||
| 3. Seed Round | 22-Jul-2013 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2010 | $7.21K | Completed | Startup | ||
| 1. Early Stage VC | 17-Sep-2009 | $7.21K | $7.21K | Completed | Startup |
Treat U Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Treat U Executive Team (2)
| Name | Title | Board Seat |
|---|---|---|
| Vera Moura Ph.D | Co-Founder, Chief Executive Officer & Board Member | |
| Sérgio Simões Ph.D | Co-Founder, Chairman & Board Member |
Treat U Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Miguel Botto | Portugal Ventures | Board Member | |
| Paulo Barradas | Bluepharma | Board Member | |
| Sérgio Simões Ph.D | Treat U | Co-Founder, Chairman & Board Member | |
| Tony Cruz Ph.D | Self | Board Member | |
| Vera Moura Ph.D | Treat U | Co-Founder, Chief Executive Officer & Board Member |
Treat U Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Treat U Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Building Global Innovators | Accelerator/Incubator | |||
| European Regional Development Fund (Brandenburg) | Government | Minority | ||
| Inovcapital | Venture Capital | Minority | ||
| João Simões | Angel (individual) | Minority | ||
| Portugal Ventures | Venture Capital | Minority |
Treat U FAQs
-
Who is the founder of Treat U?
Vera Moura Ph.D and Sérgio Simões Ph.D are the founders of Treat U.
-
Who is the CEO of Treat U?
Vera Moura Ph.D is the CEO of Treat U.
-
Where is Treat U headquartered?
Treat U is headquartered in Coimbra, Portugal.
-
What is the size of Treat U?
Treat U has 5 total employees.
-
What industry is Treat U in?
Treat U’s primary industry is Drug Delivery.
-
Is Treat U a private or public company?
Treat U is a Private company.
-
What is Treat U’s current revenue?
The current revenue for Treat U is .
-
How much funding has Treat U raised over time?
Treat U has raised $7.21K.
-
Who are Treat U’s investors?
Building Global Innovators, European Regional Development Fund (Brandenburg), Inovcapital, João Simões, and Portugal Ventures have invested in Treat U.
-
When was Treat U acquired?
Treat U was acquired on 31-Mar-2020.
-
Who acquired Treat U?
Treat U was acquired by Bluepharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
